News & Insights
Personalised medicine has been a strong focus of pharmaceutical research and development (R&D) in recent years, and we expect this to continue in 2022 and beyond, with the global personalised… read more…
Data provided by Mathys & Squire has featured in an article by City AM highlighting a surge in trade mark applications following Brexit, which has in turn increased the wait time for trade… read more…
The third article in our ‘IP trends for 2022’ series on innovation and technology focuses on cleantech innovations ranging from electric vehicles (EVs), renewable energy to… read more…
The second article in our ‘IP trends for 2022’ series on innovation and technology focuses on blockchain, its patentability and an increasing interest in non-fungible tokens Blockchain has… read more…
As part of the UK Intellectual Property Office (UKIPO)’s endeavours to encourage innovation, they have published a survey requesting feedback on the current UK designs system Launched earlier this… read more…
The first article in our ‘IP trends for 2022’ series on innovation and technology focuses on ‘Biology 20’ and how it is impacted by deep tech and artificial intelligence (AI) You may have… read more…
Mathys & Squire has featured in an article published by City AM relating to new data around global patent applications relating to Covid-19 that have been published since the start of the… read more…
Our team of patent, trade mark and design attorneys have considered the legal landscape, recent technical developments and inventions, as well as the marketplace, to predict the likely trends that… read more…
Mathys & Squire has been recognised in JUVE Patent’s UK Rankings in the ‘Patent Filing’ category for the third consecutive year in the fields of ‘Pharma and biotechnology’, ‘Medical technology’,… read more…
Sign up to our mailing list to receive Mathys Matters, our monthly newsletter covering the latest IP news, industry insights, events and case law.
If you are interested in receiving quarterly newsletters relevant to our core sector groups - IT & engineering ('Inside Wires') and life sciences & chemistry ('Under the Microscope') - please select your preference(s) below:
Please select your practice area(s) of interest:
Mathys & Squire uses cookies
We use cookies to ensure you get the best experience on our website. More details are available via our Cookie Policy.